Alejandro Gonzalez Veliz: What If Inflammation Is the Hidden Driver of Cardiovascular Disease?
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“What if inflammation is the hidden driver of cardiovascular disease?
For decades, cholesterol has been the main focus of prevention. But growing evidence shows that chronic low-grade inflammation plays a central role in atherosclerosis, plaque rupture, myocardial infarction, and heart failure.
Inflammation promotes endothelial dysfunction, foam cell formation, and vulnerable plaques.
High-sensitivity C-reactive protein (hsCRP) helps identify residual inflammatory risk—even when LDL cholesterol is well controlled.
Clinical trials such as CANTOS, COLCOT, and LoDoCo2 demonstrated that targeting inflammation can reduce cardiovascular events.
The good news?
Lifestyle remains one of the most powerful anti-inflammatory therapies:
- Mediterranean diet
- Regular exercise
- Smoking cessation
- Healthy weight management
The future of cardiovascular prevention is no longer just about lowering cholesterol. It’s about extinguishing the silent fire within the arteries.”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 13:59Ghanim Ullah: Determining the Role of NCX1 in Neurons and Astrocytes During Ischemic Stroke
-
Jun 7, 2026, 13:51Billy Alexander: Learning from Volunteers as I Begin My Journey with the Stroke Association Scotland
-
Jun 7, 2026, 12:28Thrombosis in Cancer Patients: Why It Happens and How We Treat It Today
-
Jun 7, 2026, 12:01Addressing Real-World Challenges in Thrombosis Care Through Case-Based Learning – Thrombosis Canada
-
Jun 7, 2026, 11:46Zehraan Ibni Akbar: Transforming Laboratory Data into Clinical Decisions Through Platelet Disorder Recognition
-
Jun 7, 2026, 11:31Alice Zerbinati: Y-90 Radioembolization Expands Curative Options for Advanced Hepatocellular Carcinoma
-
Jun 7, 2026, 09:26Filimon Dagnew Bezabih: SNMMI Honors 18F-GP1 PET Imaging for Innovation in Thrombosis Detection
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment